You’re cruising through a question block when a “localized inflammation after vaccination” vignette pops up—and suddenly every hypersensitivity type looks plausible. That’s exactly why the Arthus reaction is a favorite: it’s classic Type III hypersensitivity, but the distractors are usually near misses that test whether you truly understand mechanism, timing, and pathology.
Tag: Immunology > Hypersensitivity Reactions
The Clinical Vignette (Q-bank style)
A 26-year-old man receives a booster vaccine. 6 hours later, he develops pain, swelling, induration, and erythema at the injection site. The area becomes firm and tender, and by the next day there is localized tissue necrosis. He previously received multiple doses of the same vaccine.
Which mechanism best explains this reaction?
The Correct Answer: Arthus Reaction (Type III Hypersensitivity)
What’s happening mechanistically?
The Arthus reaction is a localized immune complex–mediated vasculitis that occurs when pre-existing IgG antibodies bind to antigen introduced into the skin/subcutaneous tissue (e.g., booster vaccination).
Key steps (high-yield chain):
- Antigen injected locally
- Patient has high titers of preformed IgG
- Immune complexes form in situ
- Complement activation (especially C3a, C5a) → increased vascular permeability + chemotaxis
- Neutrophil recruitment → frustrated phagocytosis, release of enzymes/ROS
- Local vasculitis, edema, hemorrhage, and sometimes necrosis
Timing
- Hours after exposure (often 4–12 hours)
- This timing is a huge clue: it’s not immediate (minutes), and it’s not delayed (days).
Pathology buzzwords you should recognize
- Immune complex deposition
- Complement activation
- Neutrophils
- Fibrinoid necrosis of vessel walls (classic immune complex vasculitis finding)
Why Every Answer Choice Matters (Systematic Distractor Breakdown)
Below is how Q-banks often try to trick you—and how to swat each distractor fast.
Distractor 1: Type I hypersensitivity (IgE-mediated mast cell degranulation)
Why it’s tempting: “After vaccine” + redness/swelling can make people think allergy.
Why it’s wrong here:
- Type I is immediate (minutes), not hours.
- Mediated by IgE bound to mast cells/basophils.
- Clinical clues would be:
- Urticaria, pruritus, flushing
- Bronchospasm/wheezing
- Hypotension/anaphylaxis
- Local injection site swelling can happen with Type I, but it’s typically rapid and itchy, not firm induration with potential necrosis.
High-yield anchor:
- Type I = minutes = IgE = mast cells
- Anaphylaxis risk; treat with epinephrine.
Distractor 2: Type II hypersensitivity (antibody-mediated cytotoxicity)
Why it’s tempting: “Antibodies causing damage” sounds close.
Why it’s wrong here:
- Type II targets antigens on cells or extracellular matrix, not soluble antigen forming complexes.
- Mechanisms include:
- Complement-mediated lysis
- Opsonization/phagocytosis
- ADCC
- Receptor dysfunction (stimulation or blockade)
Classic Type II examples to keep separate:
- Autoimmune hemolytic anemia
- Goodpasture syndrome
- ITP
- Graves disease (stimulatory)
- Myasthenia gravis (blocking)
Board-style clue: Type II often shows specific tissue targeting (RBCs, basement membrane) rather than a “deposition” phenomenon.
Distractor 3: Type IV hypersensitivity (T-cell mediated, delayed-type)
Why it’s tempting: “Induration” makes people think PPD.
Why it’s wrong here:
- Type IV is delayed: 48–72 hours, not 6–12 hours.
- Mediated by T cells, not antibodies.
- Th1 → macrophage activation (IFN-γ)
- Th17 → neutrophil recruitment (still T-cell driven)
- CD8+ cytotoxic T cells in some settings
Classic Type IV examples:
- Contact dermatitis (poison ivy, nickel)
- PPD / tuberculin skin test
- Granulomatous inflammation (TB, sarcoidosis)
Pearl:
- Type IV = days = T cells
- Induration at 48–72 hours is the testable timing.
Distractor 4: Serum sickness (systemic Type III hypersensitivity)
Why it’s tempting: It is Type III—so why isn’t it right?
Why it’s wrong here:
- Serum sickness is systemic, not localized.
- Timing is later because it requires immune complex formation and deposition throughout the body: typically 1–2 weeks after exposure (can be sooner with re-exposure, but still usually not “within hours”).
Serum sickness presentation:
- Fever
- Urticarial or morbilliform rash
- Arthralgias
- Lymphadenopathy
- Proteinuria/hematuria (immune complex nephritis)
High-yield comparison:
- Arthus = local Type III, hours, injection site
- Serum sickness = systemic Type III, days–weeks, fever/rash/arthralgia
Distractor 5: Immune thrombocytopenic purpura (ITP) / HIT-like platelet issues
Why it’s tempting: “Post-exposure antibodies” gets people thinking hematology.
Why it’s wrong here:
- These cause thrombocytopenia → petechiae, purpura, mucosal bleeding; not a focal necrotic injection site lesion.
- Different mechanism:
- ITP: IgG against platelet membrane glycoproteins → splenic clearance
- HIT: antibodies against PF4-heparin complex → platelet activation → thrombosis
Board tip: If the vignette is localized skin lesion + timing in hours + prior sensitization, think Arthus, not platelet disorders.
One Table to Lock It In: Hypersensitivity at a Glance
| Type | Mediator | Timing | Key Pathology | Classic Examples |
|---|---|---|---|---|
| I | IgE, mast cells | Minutes | Histamine, tryptase, eosinophils | Anaphylaxis, allergic rhinitis, asthma |
| II | IgG/IgM vs fixed antigen | Hours–days | Complement, opsonization, ADCC | Goodpasture, AIHA, Graves, MG |
| III | Immune complexes (IgG) | Hours (local) to weeks (systemic) | Complement + neutrophils; vasculitis | Arthus (local), serum sickness, SLE, PSGN |
| IV | T cells | 48–72 hours | Macrophages, granulomas, CD8 injury | PPD, contact dermatitis, TB granulomas |
How to Recognize Arthus Reaction in 10 Seconds (Test-Day Pattern)
Look for:
- Booster vaccination or repeated antigen exposure
- Local erythema/edema/induration
- Painful, firm lesion (may necrose)
- Hours after injection (not minutes, not days)
- Mechanism words: IgG immune complexes, complement, neutrophils, vasculitis
Micro–Path Integration: What the Stem Is Really Testing
Q-banks love to pair Arthus with:
- “High antibody titers” (prior immunizations)
- Complement consumption idea (conceptual; not usually measured in localized reactions)
- Neutrophilic inflammation in small vessels
If they mention biopsy:
- Expect fibrinoid necrosis and neutrophils around vessel walls (leukocytoclastic vasculitis pattern).
Rapid-Fire High-Yield Facts (USMLE-Friendly)
- Arthus reaction = localized Type III hypersensitivity due to preformed IgG.
- Timing: usually 4–12 hours post-exposure.
- Mechanism: immune complex deposition → complement (C3a/C5a) → neutrophils → tissue injury.
- Serum sickness is also Type III but systemic and typically 1–2 weeks after exposure.
- Type IV is 48–72 hours and T-cell mediated (PPD/contact dermatitis).
- Type I is minutes, IgE/mast cells (think itching, urticaria, anaphylaxis).